Allosteric drugs: New principles and design approaches

Area of Science:

• Biochemistry
• Pharmacology
• Drug Design

Background:

• Allosteric drugs offer unique therapeutic potential distinct from orthosteric drugs.
• Current drug design principles may not fully capture the complexities of allosteric modulation.

Purpose of the Study:

• To outline novel principles and protocols for the rational design of allosteric drugs.
• To highlight the importance of considering both binding affinity and allosteric signaling in structure-activity relationships (SARs).

Main Methods:

• Introduction of the 'directed design protocol' for simultaneous generation and adjustment of allosteric site-effector pairs.
• Discussion of key approaches including reverse perturbation, targeted analysis, and agnostic analysis.
• Highlighting promising computational methods and generative models for allosteric drug discovery.

Main Results:

• Demonstration of the necessity to consider both binding affinity and allosteric signaling for effective allosteric effector design.
• Proposal of a simultaneous optimization framework for allosteric site-effector pairs.
• Identification of computational strategies, including generative models, to accelerate the discovery of allosteric drugs.

Conclusions:

• The design of allosteric drugs necessitates a departure from traditional approaches, integrating binding and signaling properties.
• A simultaneous, directed design protocol for site-effector pairs is crucial for optimizing allosteric drug candidates.
• Advanced computational techniques, particularly generative models, hold significant promise for advancing allosteric drug discovery.